ArticleOncology letters2022

Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy.

Hiroyuki Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.